The Effect of Sickle Cell Disease on the Lung
Author:
- 1 November 2004
- journal article
- colleagues in-respiratory-medicine
- Published by Wolters Kluwer Health in Clinical Pulmonary Medicine
- Vol. 11 (6) , 369-378
Abstract
Sickle cell disease is the most common inherited disease in African Americans, affecting at least 50,000 individuals. At present, there is no cure. Despite improvement in survival, median life expectancy remains 42 years for males and 48 years for females. There is an increasing appreciation of both the acute and chronic pulmonary manifestations of sickle cell disease and their role in the morbidity and mortality of this disease. Acute manifestations include the acute chest syndrome, pulmonary thromboembolism, and episodic respiratory symptoms that suggest an asthma-phenotype. Chronic manifestations include abnormal pulmonary function, hypoxemia, evolving pulmonary hypertension, and exercise intolerance. Sickle chronic lung disease is a clinical continuum characterized by dyspnea, exercise intolerance, pleuritic chest pain, and progressive deterioration in pulmonary function. Timely cardiopulmonary assessment in both the acute and chronic setting provides ample opportunity for effective intervention. Recent insights into the pulmonary pathophysiology of sickle cell disease suggest ongoing lung injury may be related to ischemia/reperfusion, pulmonary vasculopathy, and alterations in nitric oxide metabolism. These insights offer the potential for novel therapies and management strategies that may alter the natural history of sickle cell disease.Keywords
This publication has 72 references indexed in Scilit:
- Nocturnal hypoxaemia and central-nervous-system events in sickle-cell diseaseThe Lancet, 2001
- Effect of transfusion in acute chest syndrome of sickle cell diseaseThe Journal of Pediatrics, 1995
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- Pulmonary hypertension in sickle cell diseaseThe American Journal of Cardiology, 1994
- High-Dose Intravenous Methylprednisolone Therapy for Pain in Children and Adolescents with Sickle Cell DiseaseNew England Journal of Medicine, 1994
- Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell diseaseThe Journal of Pediatrics, 1991
- Acute chest syndrome in sickle cell disease: Etiology and clinical correlatesThe Journal of Pediatrics, 1985
- Exercise-induced cardiac dysfunction in sickle cell anemiaThe American Journal of Cardiology, 1983
- Causes of death in sickle-cell disease in Jamaica.BMJ, 1982
- Occlusive pulmonary vascular disease associated with hemoglobin SC diseaseAmerican Heart Journal, 1966